Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-04-06APLS3Form 3 Filing for Apellis Pharmaceuticals, Inc.MEDIUM
This filing concerns Apellis Pharmaceuticals, Inc. and details a Tender and Support Agreement entered into on March 31, 2026. Biogen Inc. may be considered part of a "group" that beneficially owns over 10% of the outstanding Common Stock through this agreement. However, the agreement does not grant Biogen Inc. a pecuni...
Mid CapBiotechnology
2026-04-06CANF3Guy Regev Director Stock Option Holdings in Can-Fite BioPharma
This Form 3 filing discloses initial stock ownership and derivative holdings of Guy Regev, a director of Can-Fite BioPharma Ltd. The filing reports Regev's ownership of 8 ordinary shares and multiple option grants to purchase additional shares. The options include: 16 options from 2017 with a $2,826.14 exercise price e...
Nano CapBiotechnology